| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.097 | 0.2 |